By immunohistochemistry, strong FRα immunoreactivity was observed in ovarian cancers in contrast to moderate staining of FRα in borderline tumors and weak or absence of staining in benign cystadenomas/inclusion cysts (Figure 1C). The gene discussed is FOLR1; the disease is ovarian carcinoma.